Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2766

1.

Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK.

Bennett H, McEwan P, Bergenheim K, Gordon J.

Diabetes Ther. 2014 Sep 4. [Epub ahead of print]

PMID:
25185770
[PubMed - as supplied by publisher]
2.

Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia.

Oh PC, Koh KK, Sakuma I, Lim S, Lee Y, Lee S, Lee K, Han SH, Shin EK.

Int J Cardiol. 2014 Aug 7. pii: S0167-5273(14)01285-6. doi: 10.1016/j.ijcard.2014.07.075. [Epub ahead of print]

PMID:
25147070
[PubMed - as supplied by publisher]
3.

Anti-hyperglycemic activity of rutin in streptozotocin-induced diabetic rats: an effect mediated through cytokines, antioxidants and lipid biomarkers.

Niture NT, Ansari AA, Naik SR.

Indian J Exp Biol. 2014 Jul;52(7):720-7.

PMID:
25059040
[PubMed - indexed for MEDLINE]
4.

The management of patients with polycystic ovary syndrome.

Jayasena CN, Franks S.

Nat Rev Endocrinol. 2014 Oct;10(10):624-636. doi: 10.1038/nrendo.2014.102. Epub 2014 Jul 15. Review.

PMID:
25022814
[PubMed - as supplied by publisher]
5.

Adipsin is an adipokine that improves β cell function in diabetes.

Lo JC, Ljubicic S, Leibiger B, Kern M, Leibiger IB, Moede T, Kelly ME, Chatterjee Bhowmick D, Murano I, Cohen P, Banks AS, Khandekar MJ, Dietrich A, Flier JS, Cinti S, Blüher M, Danial NN, Berggren PO, Spiegelman BM.

Cell. 2014 Jul 3;158(1):41-53. doi: 10.1016/j.cell.2014.06.005.

PMID:
24995977
[PubMed - indexed for MEDLINE]
6.

Maternal and fetal outcome of mothers with gestational diabetes mellitus attending BIRDEM Hospital.

Sajani TT, Rahman MT, Karim MR.

Mymensingh Med J. 2014 Apr;23(2):290-8.

PMID:
24858157
[PubMed - indexed for MEDLINE]
7.

Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats.

Ahad A, Ganai AA, Mujeeb M, Siddiqui WA.

Toxicol Appl Pharmacol. 2014 Aug 15;279(1):1-7. doi: 10.1016/j.taap.2014.05.007. Epub 2014 May 18.

PMID:
24848621
[PubMed - indexed for MEDLINE]
8.

[Correction by vitamin D3 of disturbed metabolism in patients with diabetes mellitus types 1 and 2].

Komisarenko IuI.

Ukr Biokhim Zh. 2014 Jan-Feb;86(1):111-6. Ukrainian.

PMID:
24834724
[PubMed - indexed for MEDLINE]
9.

Compound K protects pancreatic islet cells against apoptosis through inhibition of the AMPK/JNK pathway in type 2 diabetic mice and in MIN6 β-cells.

Guan FY, Gu J, Li W, Zhang M, Ji Y, Li J, Chen L, Hatch GM.

Life Sci. 2014 Jun 27;107(1-2):42-9. doi: 10.1016/j.lfs.2014.04.034. Epub 2014 May 5.

PMID:
24802125
[PubMed - indexed for MEDLINE]
10.

[Adipokines and the metabolism of key nutrients in patients with obesity].

Kirillova OO, Vorozhko IV, Gapparova KM, Chekhonina IuG, Sentsova TB, Tutel'ian VA.

Ter Arkh. 2014;86(1):45-8. Russian.

PMID:
24754068
[PubMed - indexed for MEDLINE]
11.

Insulin supersensitivity and normoinsulinaemic hypoglycaemia in uncontrolled type 2 diabetes mellitus: clinical usefulness of 3 h assessment in the 75 g oral glucose tolerance test.

Sugiyama S, Jinnouchi H, Hieshima K, Jinnouchi T.

BMJ Case Rep. 2014 Apr 8;2014. pii: bcr2013201908. doi: 10.1136/bcr-2013-201908.

PMID:
24713709
[PubMed - in process]
12.

Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study.

Kaku K, Watada H, Iwamoto Y, Utsunomiya K, Terauchi Y, Tobe K, Tanizawa Y, Araki E, Ueda M, Suganami H, Watanabe D; Tofogliflozin 003 Study Group.

Cardiovasc Diabetol. 2014 Mar 28;13:65. doi: 10.1186/1475-2840-13-65.

PMID:
24678906
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Therapeutic vaccine against DPP4 improves glucose metabolism in mice.

Pang Z, Nakagami H, Osako MK, Koriyama H, Nakagami F, Tomioka H, Shimamura M, Kurinami H, Takami Y, Morishita R, Rakugi H.

Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):E1256-63. doi: 10.1073/pnas.1322009111. Epub 2014 Mar 17.

PMID:
24639549
[PubMed - indexed for MEDLINE]
14.

Efficacy and safety of luseogliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, placebo-controlled, phase II study.

Seino Y, Sasaki T, Fukatsu A, Sakai S, Samukawa Y.

Curr Med Res Opin. 2014 Jul;30(7):1219-30. doi: 10.1185/03007995.2014.901943. Epub 2014 Mar 19.

PMID:
24597840
[PubMed - in process]
15.

KDT501, a derivative from hops, normalizes glucose metabolism and body weight in rodent models of diabetes.

Konda VR, Desai A, Darland G, Grayson N, Bland JS.

PLoS One. 2014 Jan 30;9(1):e87848. doi: 10.1371/journal.pone.0087848. eCollection 2014.

PMID:
24498211
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Beneficial effects of Korean traditional diets in hypertensive and type 2 diabetic patients.

Jung SJ, Park SH, Choi EK, Cha YS, Cho BH, Kim YG, Kim MG, Song WO, Park TS, Ko JK, So BO, Chae SW.

J Med Food. 2014 Jan;17(1):161-71. doi: 10.1089/jmf.2013.3042.

PMID:
24456367
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effects of acute exercise and chronic exercise on the liver leptin-AMPK-ACC signaling pathway in rats with type 2 diabetes.

Yi X, Cao S, Chang B, Zhao D, Gao H, Wan Y, Shi J, Wei W, Guan Y.

J Diabetes Res. 2013;2013:946432. doi: 10.1155/2013/946432. Epub 2013 Dec 17.

PMID:
24455748
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties.

Gilardi F, Giudici M, Mitro N, Maschi O, Guerrini U, Rando G, Maggi A, Cermenati G, Laghezza A, Loiodice F, Pochetti G, Lavecchia A, Caruso D, De Fabiani E, Bamberg K, Crestani M.

J Biol Chem. 2014 Mar 7;289(10):6908-20. doi: 10.1074/jbc.M113.506394. Epub 2014 Jan 22.

PMID:
24451380
[PubMed - indexed for MEDLINE]
19.

GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.

Wang Q, Wang N, Dong M, Chen F, Li Z, Chen Y.

Clin Sci (Lond). 2014 Jul;127(2):91-100. doi: 10.1042/CS20130670.

PMID:
24444370
[PubMed - indexed for MEDLINE]
20.

Analysis of a sample of type 2 diabetic patients with obesity or overweight and at cardiovascular risk: a cross sectional study in Spain.

Lucha-López MO, Lucha-López AC, Vidal-Peracho C, Tricás-Moreno JM, Estébanez-De Miguel E, Salavera-Bordás C, Hidalgo-García C.

BMC Res Notes. 2014 Jan 21;7:48. doi: 10.1186/1756-0500-7-48.

PMID:
24443817
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk